A detailed history of Aqr Capital Management LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 63,763 shares of LUNG stock, worth $404,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,763
Previous 11,059 476.57%
Holding current value
$404,257
Previous $70,000 654.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.59 - $8.58 $294,615 - $452,200
52,704 Added 476.57%
63,763 $528,000
Q2 2024

Aug 14, 2024

SELL
$5.77 - $9.82 $280,831 - $477,949
-48,671 Reduced 81.49%
11,059 $70,000
Q1 2024

May 15, 2024

BUY
$8.71 - $14.65 $218,307 - $367,187
25,064 Added 72.3%
59,730 $553,000
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $273,514 - $455,511
34,666 New
34,666 $441,000
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $262,393 - $925,310
53,332 New
53,332 $449,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.